Evidence map›Paper›PMID 30280241›Full record

ReviewApplied microbiology and biotechnology2018

Immunobiosis and probiosis: antimicrobial activity of lactic acid bacteria with a focus on their antiviral and antifungal properties.

Mattia Pia Arena, Vittorio Capozzi, Pasquale Russo, Djamel Drider, Giuseppe Spano, Daniela Fiocco

Erratum issuedAbstract readReview
PubMed Publisher
In one paragraph

Review in Applied microbiology and biotechnology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 70 papers.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed
11.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

70 citing papers in PubMed, 125 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. In vitro characterization of probiotic properties of isolated and grown co-cultures on halophyte-based substrate.International microbiology : the official journal of the Spanish Society for Microbiology · 2026
    Article
  8. Article
  9. Review
  10. Review
  11. A sapropel-derivedFrontiers in microbiology · 2026
    Article
  12. Article
  13. Review
  14. Evaluating the Impact ofFoods (Basel, Switzerland) · 2025
    Article
  15. Article
  16. Article
  17. Article
  18. Antimicrobial Activity ofAntibiotics (Basel, Switzerland) · 2025
    Article
  19. Article
  20. Article

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Mattia Pia ArenaDipartimento di Scienze Agraria, degli Alimenti e dell'Ambiente, Università degli Studi di Foggia, 71122, Foggia, Italy.
Vittorio CapozziDipartimento di Scienze Agraria, degli Alimenti e dell'Ambiente, Università degli Studi di Foggia, 71122, Foggia, Italy.
Pasquale RussoDipartimento di Scienze Agraria, degli Alimenti e dell'Ambiente, Università degli Studi di Foggia, 71122, Foggia, Italy.
Djamel DriderUniversité de Lille-ICV-Institut Charles Viollette, EA7394. F-59000, Lille, France.
Giuseppe SpanoDipartimento di Scienze Agraria, degli Alimenti e dell'Ambiente, Università degli Studi di Foggia, 71122, Foggia, Italy. giuseppe.spano@unifg.it.
Daniela FioccoDepartment of Clinical and Experimental Medicine, University of Foggia, Foggia, Italy.
University of Foggia · ITUniversité de Lille · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lactic acid bacteria (LAB), a heterogeneous group of bacteria that produce lactic acid as the main product of carbohydrate degradation, play an important role in the production and protection of fermented foods. Moreover, beside the technological use of these microorganisms added to control and steer food fermentations, their beneficial healthy properties are largely overt. Thus, numerous LAB strains have obtained the probiotic status, which entails the ability to maintain and promote a good health of consumers. In particular, increasing consideration is being focused on probiotic microorganisms that can improve the human immune response against dangerous viral and fungal enemies. For such beneficial microbes, the term "immunobiotics" has been coined. Together with an indirect host-mediated adverse effect against undesirable microorganisms, also a direct antagonistic activity of several LAB strains has been largely demonstrated. The purpose of this review is to provide a fullest possible overview of the antiviral and antifungal activities ascribed to probiotic LAB. The interest in this research field is substantiated by a large number of studies exploring the potential application of these beneficial microorganisms both as biopreservatives and immune-enhancers, aiming to reduce and/or eliminate the use of chemical agents to prevent the development of pathogenic, infectious, and/or degrading causes.

Indexed as

LactobacillalesAnimalsAntifungal AgentsAnti-Infective AgentsAntiviral AgentsBacteriocinsBiological Control AgentsFermentationHumansProbioticsAntifungal AgentsAnti-Infective AgentsAntiviral AgentsBacteriocinsBiological Control AgentsAntifungalAntiviralLactic acid bacteriaProbiosis

Identifiers

PMID30280241
OpenAlexW2894607331

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.